Friday, September 23, 2022 Daily Archives

Terumo BCT launches hollow-fiber perfusion bioreactor for CGT

Terumo Blood and Cell Technologies (BCT) has launched the Quantum Flex Cell Expansion System, saying healthier cells and scalability are among the benefits the bioreactor platform will bring to cell and gene therapy makers. According to the firm, the Quantum Flex system was based on industry’s need for earlier automation to potentially limit additional and time-consuming steps such as bridging studies and technology transfers. Furthermore, the system allows developers to complete early process development on the same platform they will…

Valneva and IDT Biologika end COVID vaccine CDMO contract

Valneva has ended its manufacturing partnership with IDT Biologika following a reduction in demand for its COVID-19 vaccine VLA2001 from the European Commission. In November 2021, French vaccine developer Valneva signed an advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate, VLA2001, over a two period. Valneva was set to deliver 24.3 million doses during the second and third quarters of 2022, with contract development and manufacturing…